Benji T. Kurian

Psychiatry
5323 Harry Hines Blvd
Dallas, TX 75390

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial.

Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial.

Journal: Behavioral sciences (Basel, Switzerland)
Published: May 31, 2023

Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial.

Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial.

Journal: Biological psychiatry
Published: December 02, 2020

Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder.

Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder.

Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
Published: January 02, 2020

Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.

Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.

Journal: The American journal of psychiatry
Published: September 21, 2019

Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals.

Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals.

Journal: Molecular psychiatry
Published: December 11, 2018

Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial.

Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial.

Journal: EClinicalMedicine
Published: November 30, 2018

Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response.

Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response.

Journal: Journal of affective disorders
Published: September 29, 2018

Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.

Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.

Journal: Psychological medicine
Published: July 03, 2018

Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control.

Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control.

Journal: Journal of affective disorders
Published: March 28, 2018

A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial.

A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial.

Journal: Psychotherapy and psychosomatics
Published: February 28, 2018

Development and evaluation of a multimodal marker of major depressive disorder.

Development and evaluation of a multimodal marker of major depressive disorder.

Journal: Human brain mapping
Published: February 12, 2018

Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.

Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: January 16, 2018
Showing 1-12 of 36

Last Updated: 09/26/2026